BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17612040)

  • 1. A chronic HCV positive hemodialysis patient with an unusual treatment complication.
    Mousa D; Altayeb A
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):282-6. PubMed ID: 17612040
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance and efficacy of interferon-alpha in hemodialysis patients in Tripoli.
    Buargub M; El Huni S; Tagdi M
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):338-43. PubMed ID: 16970253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of intestinal diverticulosis complicated with massive intestinal hemorrhage].
    Makhovskiĭ VZ; Vorushilin VA; Nemchinov OA
    Khirurgiia (Mosk); 2008; (12):58-9. PubMed ID: 19938266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Eradication of hepatitis C virus after 3 months of interferon alpha treatment in a patient with chronic C hepatitis. A new case].
    Moreau X; Poggi C; Chollet L; Pradie MP; Profizi N
    Gastroenterol Clin Biol; 2001; 25(6-7):715-6. PubMed ID: 11673740
    [No Abstract]   [Full Text] [Related]  

  • 5. Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.
    Höftberger R; Garzuly F; Dienes HP; Grubits J; Rohonyi B; Fischer G; Hanzely Z; Lassmann H; Budka H
    Mult Scler; 2007 Nov; 13(9):1100-6. PubMed ID: 17967838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated jejunal varices.
    Bhagwat SS; Borwankar SS; Ramadwar RH; Naik AS; Gajaree GI
    J Postgrad Med; 1995; 41(2):43-4. PubMed ID: 10707708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome due to interferon-alpha.
    LaRochelle JS; Karp BI
    Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatitis C: etiology, pathogenesis, treatment].
    Maev IV; Polunina TE; Polunina EV
    Klin Med (Mosk); 2009; 87(11):12-7. PubMed ID: 20143559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V; Rousseau A; Marquet P; Denis F; Alain S
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):249-53. PubMed ID: 19344238
    [No Abstract]   [Full Text] [Related]  

  • 11. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studies.
    Beard MR
    Antivir Ther; 2004 Oct; 9(5):637-9. PubMed ID: 15535401
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid virologic response: a new milestone in the management of chronic hepatitis C.
    Poordad F; Reddy KR; Martin P
    Clin Infect Dis; 2008 Jan; 46(1):78-84. PubMed ID: 18171217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of HCV-related liver disease in the dialysis population: a novel challenge for clinical nephrologists.
    Fabrizi F; Lunghi G; Martin P
    Int J Artif Organs; 2001 Jun; 24(6):335-46. PubMed ID: 11482499
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
    Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.
    Fisher ME; Rossini M; Simmons E; Harris RC; Moeckel G; Zent R
    Am J Kidney Dis; 2004 Sep; 44(3):567-73. PubMed ID: 15332232
    [No Abstract]   [Full Text] [Related]  

  • 20. Massive increase of insulin resistance in a patient with chronic hepatitis C after treatment with interferon.
    Chatterjee S
    J Assoc Physicians India; 2004 Jun; 52():514. PubMed ID: 15645973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.